Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

William E. Rosa

47 indexed publications match this author name.

ORCID: 0000-0002-0680-8911
OpenAlex: https://openalex.org/A5000784145

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 16 Receptor Pharmacology 13 Mechanism of Action 11 Safety 11 Toxicity 11 Clinical Trial 10 Chronic Pain 9 Anxiety 9 Observational Study 8 Brain Imaging 8 Wellbeing 8 Emotional Processing 8

Journals

Journal of Psychopharmacology 4 Scientific Reports 3 PsyArXiv 3 bioRxiv 2 Psychopharmacology 2 Journal of Humanistic Psychology 2 Molecular Psychiatry 1 Biomolecules 1

Publication history

α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in mice.Molecular Psychiatry · 2026-07-06 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentBiomolecules · 2026-07-02 Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical DevelopmentUniversity of Groningen research database (University of Groningen / Centre for Information Technology) · 2026-06-28 A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy studyInternational Journal of Drug Policy · 2026-06-04 Time to embrace the whole: considering the replacement of psilocybin with Psilocybe spp. in psychedelic research and therapyNatural Product Research · 2026-06-01 Neural correlates of insight on psilocybin: a within-subjects, healthy volunteer studyUnknown journal · 2026-05-07 Human brain changes after first psilocybin use.Unknown journal · 2026-05-04 Observing the mind under psychedelics: conceptual metaphors used following four once-weekly macrodoses of psilocybinPhilosophical Psychology · 2026-04-09 Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteersBMJ Open · 2026-02-28 Standardization of Psilocybin Dosing in a Natural Product-Based Retreat Setting: A Practical Method for Dose Quantification and Adjustment Across SessionsResearch Square · 2025-11-16 High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley ratsJournal of Psychopharmacology · 2025-09-21 Meaning-Centered Psychotherapy for Psilocybin-Assisted Therapy Among Patients with Advanced Cancer and Depression: Rationale and Preliminary Evaluation of MCP-PSIL.Unknown journal · 2025-07-29 FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30 A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association · 2025-03-31 Improved LC-MS Detection of Opioids, Amphetamines, and Psychedelics Using TrEnDiJournal of the American Society for Mass Spectrometry · 2025-02-02 Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-01-31 International Drug Policy Study Trends With Psychedelic Drugs: A Spotlight on Psilocybin, LSD, and MDMADrug and Alcohol Dependence · 2025-01-31 From relaxed beliefs under psychedelics (REBUS) to revised beliefs after psychedelics (REBAS)Scientific Reports · 2025-01-28 A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.Unknown journal · 2024-12-18 Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods studyScientific Reports · 2024-11-20 Expert recommendations for Germany's integration of psychedelic-assisted therapy.Unknown journal · 2024-10-23 Human brain changes after first psilocybin usebioRxiv · 2024-10-13 Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distressFrontiers in Psychiatry · 2024-04-17 Psychedelics and the ‘inner healer’: Myth or mechanism?Journal of Psychopharmacology · 2024-04-11 Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depressionJournal of Psychopharmacology · 2024-03-21 Development of a digital intervention for psychedelic preparation (DIPP)Scientific Reports · 2024-02-18 Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depressionPsychological Medicine · 2024-01-21 The entropic heart: Tracking the psychedelic state via heart rate dynamicsbioRxiv · 2023-11-08 Extended difficulties following the use of psychedelic drugs: A mixed methods studyPLoS ONE · 2023-10-23 Applying Key Lessons from the Hospice and Palliative Care Movement to Inform Psychedelic-Assisted Therapy.Psychedelic medicine (New Rochelle, N.Y.) · 2023-08-31 Canalization and plasticity in psychopathology.Unknown journal · 2022-12-26 Body mass index (BMI) does not predict responses to psilocybin.Journal of Psychopharmacology · 2022-11-13 A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for Depression.Psychedelic Medicine · 2022-10-27 The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.Psychopharmacology · 2022-08-07 Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.Journal of palliative medicine · 2022-07-31 From Relaxed Beliefs Under Psychedelics (REBUS) to Revised Beliefs After Psychedelics (REBAS): Preliminary Development of the RElaxed Beliefs Questionnaire (REB-Q)PsyArXiv · 2022-07-06 Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses.Neuroscience and biobehavioral reviews · 2022-06-30 A Bayesian Reanalysis of a Trial of Psilocybin versus Escitalopram for DepressionPsyArXiv · 2022-06-30 Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in Pharmacology · 2022-03-30 Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online surveyPsychopharmacology · 2021-11-03 Psychedelic resting-state neuroimaging: a review and perspective on balancing replication and novel analysesPsyArXiv · 2021-06-09 Psychedelic-Assisted Psychotherapy Practices and Human Caring Science: Toward a Care-Informed Model of TreatmentJournal of Humanistic Psychology · 2021-04-22 Trial of Psilocybin versus Escitalopram for Depression.New England Journal of Medicine · 2021-03-31 The use of the psychological flexibility model to support psychedelic assisted therapyJournal of Contextual Behavioral Science · 2019-12-13 Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant DepressionJournal of Humanistic Psychology · 2017-06-18 Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The International Journal of Neuropsychopharmacology · 2016-07-04 Broadband cortical desynchronization underlies the human psychedelic state.Journal of Neuroscience · 2013-08-31

Author directory